Literature DB >> 666393

The development of Schistosoma haematobium in the hamster.

A M Ghandour.   

Abstract

The in vivo development of Schistosoma haematobium in the hamster was studied. Six stages of development were distinguished on the basis of morphological and histochemical criteria. Schistosomula reached the lung (stage 1) on day three post-infection, with maximum concentrations on day nine. Gut formation occurred in the second stage at day 18. In stage 3 'Organogeny' (day 24) males developed one testis and females a narrow uterus. Pairing and the development of males with sperm-containing testes and females with an ovary characterize stage 4 (day 28). In stage 5 (day 53) vitelline follicles begin to develop in the females. The final stage, oviposition, occurred on days 61-63 and was characterized by the appearance of fully developed eggs in the uterus.

Entities:  

Mesh:

Year:  1978        PMID: 666393     DOI: 10.1080/00034983.1978.11719309

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  7 in total

Review 1.  Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials.

Authors:  Jürg Utzinger; Jennifer Keiser; Xiao Shuhua; Marcel Tanner; Burton H Singer
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  Hamster Weight Patterns Predict the Intensity and Course of Schistosoma haematobium Infection.

Authors:  Thien-Linh P Le; Deborah M Boyett; Amelia Hurley-Novatny; Michael H Hsieh
Journal:  J Parasitol       Date:  2015-07-17       Impact factor: 1.276

3.  Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.

Authors:  Souvik Karmakar; Weidong Zhang; Gul Ahmad; Workineh Torben; Mayeen U Alam; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; David W Carey; Darrick Carter; Steven G Reed; Afzal A Siddiqui
Journal:  Vaccine       Date:  2014-01-04       Impact factor: 3.641

4.  Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.

Authors:  Adebayo J Molehin; Souad R Sennoune; Weidong Zhang; Juan U Rojo; Arif J Siddiqui; Karlie A Herrera; Laura Johnson; Justin Sudduth; Jordan May; Afzal A Siddiqui
Journal:  Parasitol Res       Date:  2017-10-12       Impact factor: 2.289

5.  A novel mouse model of Schistosoma haematobium egg-induced immunopathology.

Authors:  Chi-Ling Fu; Justin I Odegaard; De'Broski R Herbert; Michael H Hsieh
Journal:  PLoS Pathog       Date:  2012-03-29       Impact factor: 6.823

Review 6.  Syrian Hamster as an Animal Model for the Study on Infectious Diseases.

Authors:  Jinxin Miao; Louisa S Chard; Zhimin Wang; Yaohe Wang
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

7.  Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children.

Authors:  Katarina Stete; Stefanie J Krauth; Jean T Coulibaly; Stefanie Knopp; Jan Hattendorf; Ivan Müller; Laurent K Lohourignon; Winfried V Kern; Eliézer K N'goran; Jürg Utzinger
Journal:  Parasit Vectors       Date:  2012-12-21       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.